Episode
Breaking Barriers in Nanomedicine with Priya Kumthekar, MD
- Published
- Mar 3, 2025
- Duration seconds
- 1309
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/nanoscape-exploring-the-frontiers-ahead-6988860/episodes/breaking-barriers-in-nanomedicine-with-priya-kumthekar-md/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/nanoscape-exploring-the-frontiers-ahead-6988860/breaking-barriers-in-nanomedicine-with-priya-kumthekar-md.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode, Northwestern Medicine neuro-oncologist, Priya Kumthekar, MD , discusses her pioneering work in nanomedicine on an early clinical trial in individuals with the deadly brain cancer glioblastoma. The study showed an experimental spherical nucleic acid drug, developed by Northwestern University scientists, was able to penetrate the blood-brain barrier and trigger the death of tumor cells. This was the first time a nanotherapeutic has been shown to cross the blood-brain barrier. The study set a precedent at Northwestern University and has opened the door for similar studies and innovations to take place here.